Transition metal compounds as cancer radiosensitizers

Transition metal compounds as cancer radiosensitizers

The concomitant administration of ionising radiation (IR) in the form of external beam radiotherapy or targeted radionuclide therapy (TRT) alongside radiosensitizing small molecules is a highly successful strategy for the treatment of cancer. The major clinical impact of the radiosensitizing platinu...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Gill, M, Vallis, K
Format:	Journal article
Wydane:	Royal Society of Chemistry 2018

Podobne zapisy

A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
od: Gill, M, i wsp.
Wydane: (2016)

Radiosensitivity of colorectal cancer to 90Y and the radiobiological implications for radioembolisation therapy
od: Lee, B, i wsp.
Wydane: (2019)

111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells
od: Gill, M, i wsp.
Wydane: (2018)

Enhancement of radiosensitization by metal-based nanoparticles in cancer radiation therapy
od: Xiang-Yu Su, i wsp.
Wydane: (2014-06-01)

Megavoltage radiosensitization of gold nanoparticles on a Glioblastoma Cancer Cell Line using a clinical platform
od: Kazmi, F, i wsp.
Wydane: (2020)

Predisposition to cancer and radiosensitivity
od: P. Pichierri, i wsp.
Wydane: (2000-12-01)

A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
od: Gill, Martin R., i wsp.
Wydane: (2016)

Application of Radiosensitizers in Cancer Radiotherapy
od: Gong L, i wsp.
Wydane: (2021-02-01)

Vitamin D Enhances Radiosensitivity of Colorectal Cancer by Reversing Epithelial-Mesenchymal Transition
od: Xinyue Yu, i wsp.
Wydane: (2021-08-01)

Trastuzumab-resistant breast cancer cells remain sensitive to the auger electron-emitting radiotherapeutic agent 111In-NLS-trastuzumab and are radiosensitized by methotrexate.
od: Costantini, D, i wsp.
Wydane: (2008)

A three-in-one-bullet for oesophageal cancer: replication fork collapse, spindle attachment failure and enhanced radiosensitivity generated by a ruthenium(II) metallo-intercalator
od: Gill, MR, i wsp.
Wydane: (2017)

Methotrexate, paclitaxel, and doxorubicin radiosensitize HER2-amplified human breast cancer cells to the Auger electron-emitting radiotherapeutic agent (111)In-NLS-trastuzumab.
od: Costantini, D, i wsp.
Wydane: (2010)

Oligonucleotide-functionalized gold nanoparticles for synchronous telomerase inhibition, radiosensitization, and delivery of theranostic radionuclides
od: Bavelaar, BM, i wsp.
Wydane: (2021)

Mutual communication between radiosensitive and radioresistant esophageal cancer cells modulates their radiosensitivity
od: Congying Xie, i wsp.
Wydane: (2023-12-01)

Radiosensitization: Studies and Modern Approaches to Cellular Radiosensitivity
od: Juan C. Alamilla-Presuel
Wydane: (2023-09-01)

Metal-metal bonds in transition metal compounds /
od: 432473 Baird, Micheal C.

Targeting the organelle for radiosensitization in cancer radiotherapy
od: Xiaoyan Sun, i wsp.
Wydane: (2024-04-01)

Inorganic Nanoparticles as Radiosensitizers for Cancer Treatment
od: Balaashwin Babu, i wsp.
Wydane: (2023-10-01)

Editorial: Regulators of radiosensitivity in colorectal cancer
od: Kumar Bishnupuri, i wsp.
Wydane: (2022-11-01)

Radiosensitizers in cervical cancer. Cisplatin and beyond
od: Cetina Lucely, i wsp.
Wydane: (2006-05-01)

Radiosensitization in prostate cancer: mechanisms and targets
od: Palacios Diego A, i wsp.
Wydane: (2013-01-01)

Radiosensitivity of atovaquone on human penile cancer cells
od: Z. Li, i wsp.
Wydane: (2020-07-01)

Compounds of the transition elements involving metal-metal bonds/
od: 289898 Kepert, D. L., i wsp.
Wydane: (1973)

Transition metal cluster compounds /
od: 232035 King, R. Bruce

Abstract: Deferoxamine Increases Breast Cancer Radiosensitivity
od: Kavitha Ranganathan, MD, i wsp.
Wydane: (2018-09-01)

Three-in-One Nanozyme for Radiosensitization of Bladder Cancer
od: Li Y, i wsp.
Wydane: (2024-10-01)

Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers
od: Vasiliki Zoi, i wsp.
Wydane: (2022-01-01)

Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer
od: Sandra Cotino-Nájera, i wsp.
Wydane: (2023-11-01)

Application of nano‐radiosensitizers in combination cancer therapy
od: Mohammad Varzandeh, i wsp.
Wydane: (2023-05-01)

Targeting Mcl-1 for Radiosensitization of Pancreatic Cancers
od: Dongping Wei, i wsp.
Wydane: (2015-02-01)

Microdosimetric Investigation and a Novel Model of Radiosensitization in the Presence of Metallic Nanoparticles
od: Huagang Yan, i wsp.
Wydane: (2021-12-01)

Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme
od: Jinyeong Choi, i wsp.
Wydane: (2020-09-01)

The potential of HSA-stabilized zinc oxide nanoparticles as radiosensitizers to enhance the cytotoxic effects and radiosensitivity of cervical cancer cells
od: Chanyatip Suwannasing, i wsp.
Wydane: (2024-11-01)

Magnetic properties of transition metal compounds/
od: Carlin, Richard L. (Richard Lewis), 1935-, i wsp.
Wydane: (1977)

TRANSITION METALS COORDINATION COMPOUNDS WITH BENZOHYDRAZID
od: T. V. Koksharova, i wsp.
Wydane: (2017-03-01)

Imatinib radiosensitizes bladder cancer by targeting homologous recombination.
od: Qiao, B, i wsp.
Wydane: (2013)

Cytotoxicity, dose-enhancement and radiosensitization and Radiosensitization of glioblastoma cells with Rare Earth nanoparticles
od: Lu, V, i wsp.
Wydane: (2019)

Targeting acid ceramidase to improve the radiosensitivity of rectal cancer
od: Clifford, R, i wsp.
Wydane: (2020)

Olaparib nanoparticles potentiated radiosensitization effects on lung cancer
od: Wu M, i wsp.
Wydane: (2018-12-01)

Investigation of radiosensitivity gene signatures in cancer cell lines.
od: John S Hall, i wsp.
Wydane: (2014-01-01)